Haem metabolic aspects on nitric oxide formation in endotoxaemia.
Sakaguchi
S
S
First Department of Hygienic Chemistry, Tohoku Pharmaceutical University, Sendai, Japan. shuhei@tohoku-pharm.ac.jp
Iizuka
Y
Y
Furusawa
S
S
Takayanagi
M
M
Satoh
S
S
D000818:Animals; D002460:Cell Line; D002570:Ceruloplasmin / Q000378:metabolism; D003035:Cobalt / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003676:Deferoxamine / Q000494:pharmacology; D019446:Endotoxemia / Q000209:etiology / Q000378:metabolism*; D004731:Endotoxins / Q000008:administration & dosage; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism*; D007501:Iron / Q000097:blood; D008070:Lipopolysaccharides / Q000008:administration & dosage; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology; D009569:Nitric Oxide / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar
D004731:Endotoxins; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D003035:Cobalt; D003577:Cytochrome P-450 Enzyme System; D007501:Iron; D006419:Heme Oxygenase (Decyclizing); D002570:Ceruloplasmin; C018021:cobaltous chloride; D003676:Deferoxamine